$HCWB Going Nuclear Premarket 🚀 Up 129% 🔹 Massive premarket surge after HCW Biologics reported Q1 revenue of $6.53M and GAAP EPS of $0.37 📈 🔹 Clinical-stage

$HCWB Going Nuclear Premarket 🚀 Up 129% 🔹 Massive premarket surge after HCW Biologics reported Q1 revenue of $6.53M and GAAP EPS of $0.37 📈 🔹 Clinical-stage biotech focused on immunotherapies targeting chronic inflammation, aging-related diseases, and solid tumors 🧬 🔹 Recent T-cell engager upd…